Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Healthy You
    • Job listings
    • Q&As
    • Special sections
  • Multimedia
    • Quiz
    • Podcasts
    • Videos
  • FAQs
    • Advertising
    • Subscriptions
    • For APHA members
    • Internships
    • Change of address
  • About
    • About The Nation's Health
    • Submissions
    • Permissions
    • Purchase articles
    • Join APHA
  • Contact us
    • Feedback
  • APHA
    • AJPH
    • NPHW

User menu

  • My alerts

Search

  • Advanced search
The Nation's Health
  • APHA
    • AJPH
    • NPHW
  • My alerts
The Nation's Health

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Healthy You
    • Job listings
    • Q&As
    • Special sections
  • Multimedia
    • Quiz
    • Podcasts
    • Videos
  • FAQs
    • Advertising
    • Subscriptions
    • For APHA members
    • Internships
    • Change of address
  • About
    • About The Nation's Health
    • Submissions
    • Permissions
    • Purchase articles
    • Join APHA
  • Contact us
    • Feedback
  • Follow The Nation's Health on Twitter
  • Follow APHA on Twitter
  • Visit APHA on Facebook
  • Follow APHA on Youtube
  • Follow APHA on Instagram
  • Follow The Nation's Health RSS feeds
NewsWeb-only News

Generic drugs offer big Medicare savings, but are not always dispensed

Kim Krisberg
The Nation's Health May 2021, 51 (3) E6;
Kim Krisberg
  • Search for this author on this site

The U.S. Medicare program could save more than $1 billion annually if generic prescriptions were consistently provided over brand-name ones, a recent study finds.

Published in March in JAMA Network Open, the study is based on 2017 prescription drug claims from Medicare Part D, which offers supplemental outpatient drug coverage and accounts for about one-third of prescription drug spending in the U.S. Of the 169 million filled prescriptions analyzed in the study, 8.5 million involved a brand-name drug when a generic was available.

Researchers found that the Medicare Part D program would have saved $977 million in one year if all branded drugs requested by clinicians had been generic instead. In addition, if patients had requested generics instead of brand-name drugs, the program would have saved $673 million in the same year, saving a total of $1.7 billion.

Laws are in place in every U.S. state and the District of Columbia that promote generic drug dispensing. But in cases where a brand-name drug was dispensed in 2017, clinicians and patients requested brand name prescription drugs 30% of the time.

“Even with laws in place, requesting a brand name drug happens way more frequently than it should,” study author Gerard Anderson, PhD, professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health said in a news release. “This dispensing pattern results in exponentially higher costs for both the Medicare Part D program and patients.”

While some clinicians or patients mistrust generic drugs, research shows they are as safe and effective as brand-name drugs. Patients taking expensive brand-name drugs are also more likely to skip doses or split pills to try and save money, and less likely to fill their prescriptions.

“Policy initiatives aimed at containing prescription drug spending should consider discouraging prescribers and patients from requesting branded dispensing,” the study said.

Read the full study online at https://bit.ly/3d4les8.

  • Copyright The Nation’s Health, American Public Health Association

Popular features

  • Healthy You
  • Special sections
  • Q&As
  • Quiz
  • Podcasts

FAQs

  • Advertising
  • Subscriptions
  • For APHA members
  • Submissions
  • Change of address

APHA

  • Join APHA
  • Annual Meeting
  • NPHW
  • AJPH
  • Get Ready
  • Contact APHA
  • Privacy policy

© 2025 The Nation's Health

Powered by HighWire